Cefoprox CV-325
Cefoprox CV-325 is a tablet made by Cipla that contains Cefpodoxime 200 mg + Clavulanic acid 125 mg. It combines Cefpodoxime: antibiotic (cephalosporin) and Clavulanic acid: antibiotic booster.
| Ingredient (salt) | Amount |
|---|---|
| Cefpodoxime | 200 mg |
| Clavulanic acid | 125 mg |
Cefpodoxime
What it is used for
Treats throat, chest, sinus, ear, skin and urine infections.
How it works
An oral third-generation cephalosporin for chest, throat, ear, urinary and skin infections.
How to take it
Usually 100 to 200 mg twice a day with food. Finish the full course.
Common side effects
- Diarrhoea
- Nausea
- Stomach pain
Get medical help straight away if
- Severe diarrhoea
- Rash with blistering
- Allergic swelling
Be careful
Finish the course; can cause loose motions.
Other medicines and interactions
Antacids and acid reducers reduce absorption. Caution with penicillin allergy.
Pregnancy and breastfeeding
Considered acceptable in pregnancy and breastfeeding.
Clavulanic acid
What it is used for
Protects amoxicillin from bacteria that would otherwise destroy it, so it works on more infections.
How it works
Clavulanic acid blocks the beta-lactamase enzyme some bacteria use to destroy amoxicillin, so the pair (co-amoxiclav) works against more germs.
How to take it
Taken in the combination tablet at the start of a meal, usually twice or three times a day. Take at evenly spaced times and finish the full course even when you feel better, unless your doctor says otherwise.
Common side effects
- Diarrhoea
- Nausea
- Vomiting
- Thrush
Get medical help straight away if
- Yellow skin or eyes, dark urine (liver problem, can appear weeks later)
- Allergic reaction
- Severe diarrhoea
Be careful
Can cause loose motions; take with food.
Other medicines and interactions
Penicillin allergy rules apply. Can affect warfarin.
Pregnancy and breastfeeding
Generally considered acceptable in pregnancy (avoided near preterm birth) and while breastfeeding.
Same composition, other brands (8)
Ask your doctor or pharmacist before switching brands.
Common questions
What is Cefoprox CV-325?
Cefoprox CV-325 is a tablet by Cipla containing Cefpodoxime 200 mg + Clavulanic acid 125 mg.
What is Cefoprox CV-325 used for?
Treats throat, chest, sinus, ear, skin and urine infections. Protects amoxicillin from bacteria that would otherwise destroy it, so it works on more infections.
How should I take Cefoprox CV-325?
Usually 100 to 200 mg twice a day with food. Finish the full course. Taken in the combination tablet at the start of a meal, usually twice or three times a day. Take at evenly spaced times and finish the full course even when you feel better, unless your doctor says otherwise. Always follow the dose your doctor or the pack gives.
What are the side effects of Cefoprox CV-325?
Common side effects include: Diarrhoea, nausea, stomach pain, Diarrhoea, nausea, vomiting, thrush. Get medical help straight away for: Severe diarrhoea, rash with blistering, allergic swelling, Yellow skin or eyes, dark urine (liver problem, can appear weeks later), allergic reaction, severe diarrhoea.
Does Cefoprox CV-325 need a prescription?
Yes. In India it is a prescription (Schedule H) medicine, so a pharmacist should sell it only with a doctor's prescription.
Can I take Cefoprox CV-325 in pregnancy or while breastfeeding?
Considered acceptable in pregnancy and breastfeeding. Generally considered acceptable in pregnancy (avoided near preterm birth) and while breastfeeding.
What are the substitutes for Cefoprox CV-325?
Brands with the same composition: Gudcef CV 200, Polypod CV 200, Opox-CV 200, Foloup-CV 200, Cepodem XP 325, Microcef CV 200, Kefmax CV 200, Pecef Duo-200. Ask your doctor or pharmacist before switching.
Sources and further reading
- Cefpodoxime: NHS · MedlinePlus
- Clavulanic acid: NHS · MedlinePlus
NHS (UK National Health Service) and MedlinePlus (US National Library of Medicine) are free, reviewed medicine guides. Brand names and doses there may differ from India.
Composition checked against pack details from large Indian online pharmacies. Last reviewed 31 October 2026. Written by Satya Babu.
🔎 Search another medicine